The Diagnostic and Therapeutic Use of Monoclonal Antibodies in Colorectal Cancer

Monoclonal antibody technology has provided a means of specifically targeting tumor cells which has proven potential for use in radioimmunodetection and immunotherapy of malignant diseases. Numerous preclinical and clinical trials have demonstrated the applicability of monoclonal antibodies in the diagnosis and treatment of colorectal carcinoma.